← Leaderboards
Xiaoning Bi
University Of California Irvine
$4,059,320
Attributed
$4,412,618
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $489.3K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,412,618 · 4
By mechanism
R15$1,700,708 · 1
P01$1,145,568 · 1
R01$859,745 · 1
R41$706,597 · 1
Top collaborators
- Michel Baudry3 shared
Most similar at University Of California Irvine
Same institution · by research overlap
- Gary S Lynch$10,176,242
- Ruth A. Mulnard$1,191,667
- Larry E. Overman$11,686,672
- Ira T Lott$14,129,643
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsBrainWild Type MousePlayNerve DegenerationSynapsesLearningMediatingInflammationHippocampusPharmaceutical PreparationsAffectImpaired CognitionImpairmentExhibitsPropertyMouse ModelLeadNeuropathologyEpilepsyPathogenesisNervous System DisorderNeurodegenerative DisordersMemory
Grant awards (18)
Investigating the roles of UBE3A and TRPML1 in extracellular vesicle regulation to understand Angelman syndrome pathogenesis$429,000
R15 · FY2025 · MH · contact PI
Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy$197,842
R41 · FY2024 · NS
Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy$19,487
R41 · FY2024 · NS
Testing the effects of a selective calpain-2 inhibitor on spontaneous recurrent seizures in mouse models of epilepsy$489,268
R41 · FY2023 · NS
Mechanistic studies of cognition impairment in Angelman Syndrome$423,000
R15 · FY2021 · MH · contact PI
Ube3a and PKA regulation of SK2 channels$423,000
R15 · FY2017 · MH · contact PI
Regulation of SK2 channels by UBE3A$425,708
R15 · FY2014 · MH · contact PI
Neurodegeneration in Niemann-Pick Type C Disease$18,670
R01 · FY2009 · NS · contact PI
Neurodegeneration in Niemann-Pick Type C Disease$208,252
R01 · FY2008 · NS · contact PI
BDNF and Neuroprotection Mechanisms and Applications$269,921
P01 · FY2007 · NS · contact PI
Neurodegeneration in Niemann-Pick Type C Disease$208,252
R01 · FY2007 · NS · contact PI
BDNF and Neuroprotection Mechanisms and Applications$221,102
P01 · FY2006 · NS · contact PI
Neurodegeneration in Niemann-Pick Type C Disease$214,471
R01 · FY2006 · NS · contact PI
BDNF and Neuroprotection Mechanisms and Applications$214,432
P01 · FY2005 · NS
Neurodegeneration in Niemann-Pick Type C Disease$162,104
R01 · FY2005 · NS
Neurodegeneration in Niemann-Pick Type C Disease$47,996
R01 · FY2005 · NS
BDNF and Neuroprotection Mechanisms and Applications$203,793
P01 · FY2004 · NS
BDNF and Neuroprotection Mechanisms and Applications$236,320
P01 · FY2003 · NS